Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

EXP6155

Known as: 1H-Imidazole-5-acetic acid, 2-butyl-1-((4-carboxyphenyl)methyl)-4-chloro-, disodium salt, EXP 6155, EXP-6155 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1991
Review
1991
Some simple JV-benzylimidazoles, originally described by Takeda Chemical Industries (Osaka, Japan), were characterized to be very… Expand
  • figure 1
  • figure 3
  • table 1
  • figure 2
  • figure 4
Review
1990
Review
1990
Although the most direct way to interfere with the renin-angiotensin system (RAS) is at the level of the angiotensin II (AII… Expand
Review
1990
Review
1990
The most direct approach to block the function of the renin-angiotensin system would be to antagonize angiotensin II (AII) at the… Expand
Highly Cited
1989
Highly Cited
1989
EXP6155 (2-n-butyl-l-[4-carboxybenzyl]-4-chloroimidazole-5-acetic acid) and EXP6803 (methyl 2-n-butyl-l-[4-(2-carfooxybenzamido… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
1989
Highly Cited
1989
A series of 1-benzylimidazole-5-acetate derivatives defining the critical substituents on the phenyl ring was synthesized in… Expand